A subsidiary of the International Society of Automation
Cancel
Search Sponsored By Sponsor

IPS participates in workshops at INTERPHEX

  • April 04, 2007
  • Schneider Electric
  • News

Summary

FOXBORO, MASSACHUSETTS, USA - APRIL 4, 2007 - Experts from Invensys' pharmaceutical and biotechnology practices will help explore the relationship between enterprise integration and operational excellence in three separate workshops during the INTERPHEX 2007 conference at the Jacob K. Javits Center, New York, April 24 -26. The Invensys experts will join operations specialists from Genentech, Wyeth, Johnson & Johnson, Microsoft, and noted industry consultant, Dennis Brandl, in three conference sessions. In the first event, "Operational and Business Excellence: How do you measure where you are and what measures can you make to improve efficiencies," Janice Abel, Invensys director pharmaceutical and biotechnical industries, will participate in a panel including Catherine Middelberg, Wyeth manager; Stephen Dinka, Genentech associate director of engineering and business operations; Tony Cann, Genentech senior manager for operational excellence; and Ruediger Dorn, Microsoft director for the worldwide pharmaceutical industry. Panelists will discuss global market trends and their impact on manufacturing operations and performance. Topics covered will include PAT (Process Analytical Technology), Six Sigma, operations optimization, maximizing collaboration, automation integration, and measuring performance. This panel will take place in room MG2 at the Javits Center on Tuesday, April 24th, from 9:00 to 11:30 AM. In the second event, "Operational Excellence: More than a Program for Integrating Control and MES; Real Business Benefits," Charlie Nicastro, Invensys director of business development for the pharmaceutical industry; will join Gordon Kosovan, Johnson & Johnson pharmaceutical technology and global plant standards specialist; in presenting the benefits of Johnson & Johnson's Operational Excellence program. This presentation will take place in room IT4 on Tuesday, April 24th, from 2:00 to 3:00 PM. And on Wednesday, Jim Huff, Invensys global industry marketing director for specialty chemicals and pharmaceuticals, and Don Clark, Invensys global industry marketing director (and co-chair of the ISA S95 steering committee), will join Dennis Brandl, BR&L Consulting president, in the workshop "S95 and What it Means for the Pharmaceutical and Biotechnology Industries." Brandl is widely known throughout the industry as the editor in chief of the ISA S95 standard. Panelists will share their experiences in applying the standard and the benefits that S95 brings to the pharmaceutical and biotechnology industries. This will take place in room IT9 on Wednesday, April 25th, from 2:00 to 4:15 PM. In addition to participation in the conference program, Invensys Process Systems will be demonstrating its comprehensive solution set for assisting pharmaceutical and bio-science manufacturers in optimizing assets to achieve operational excellence at INTERPHEX Booth #1801. The Invensys line-up includes technologies and services that reduce risk, lower costs, improve quality, and shorten time to market through easy, standards-driven enterprise integration and control of systems, technologies, and information, including solutions in the following areas:
  • Enterprise Control Systems that can help unify all plant and enterprise systems into a common application environment
  • Process/Batch Control Systems and legacy system migration with minimal risk and process downtime
  • Asset Management Systems, including predictive/preventive maintenance solutions and condition monitoring (including wireless condition monitoring)
  • Plant Management Systems to track and manage data and provide real-time decision support
  • Intelligent Process Measurements for sanitary, high-purity, and other life sciences applications
  • Risk and compliance management, including validation planning and consulting
  • Process modeling simulation, which enables identification of process problem areas without affecting live processes
  • Production automation training, including courses on control systems, advanced process control, instrumentation, and regulatory compliance
  • Project management and other regulatory enterprise performance services that reduce risk, enforce global standards, and accelerate speed to marketThe 2007 Annual INTERPHEX Conference and Expo will take place April 24-26 in New York, New York, uniting industry leaders, manufacturers, and engineers to hear the latest on innovation and technology for the pharmaceutical and biotechnology industries. About InvensysInvensys is the world leader in industrial asset performance management, a strategy designed to help today's industrial enterprises to effectively balance the availability and utilization of their production assets to match changing business requirements. In addition to its rapidly expanding Global Solutions and Performance Management services groups, Invensys' automation businesses includes industry-leading brands such as Foxboro, Triconex, SimSci-Esscor, Validation Technologies, Wonderware, and Avantis, whose products are installed in more than 100,000 plants across the world. These range from small hybrid and batch plants to the world's largest upstream projects, refineries, gas plants, petrochemicals plants, power plants, and pulp and paper mills. The Invensys Group is headquartered in London and is listed on the London Stock Exchange, with approximately 30,000 employees working in 60 countries. Learn More

    Did you enjoy this great article?

    Check out our free e-newsletters to read more great articles..

    Subscribe